Search: id:"swepub:oai:prod.swepub.kib.ki.se:147223156" >
'Palliative-D'-Vita...
'Palliative-D'-Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial
-
- Frankling, MH (author)
- Karolinska Institutet
-
- Klasson, C (author)
- Karolinska Institutet
-
Sandberg, C (author)
-
show more...
-
Nordstrom, M (author)
-
- Warnqvist, A (author)
- Karolinska Institutet
-
- Bergqvist, J (author)
- Karolinska Institutet
-
- Bergman, P (author)
- Karolinska Institutet
-
- Bjorkhem-Bergman, L (author)
- Karolinska Institutet
-
show less...
-
(creator_code:org_t)
- 2021-07-23
- 2021
- English.
-
In: Cancers. - : MDPI AG. - 2072-6694. ; 13:15
- Related links:
-
https://www.mdpi.com...
-
show more...
-
http://kipublication...
-
https://doi.org/10.3...
-
show less...
Abstract
Subject headings
Close
- The aim of the ‘Palliative-D’ study was to test the hypothesis that correction of vitamin D deficiency reduces opioid use in cancer patients admitted to palliative care. A multicenter randomized, placebo-controlled, double-blind trial in three home-based palliative care facilities in Sweden was performed. Patients with advanced cancer and 25-hydroxyvitamin D < 50 nmol/L were randomized to vitamin D3 4000 IU/day or placebo for 12 weeks. The primary endpoint was the difference of long-acting opioid use (fentanyl ug/h) between the groups during 12 weeks, based on four time points. Secondary outcomes included changes in antibiotic use, fatigue and Quality of Life (QoL). A total of 244 patients were randomized, and 150 patients completed the 12 weeks. The major reason for drop-out was death due to cancer. The vitamin D-group had a significantly smaller increase of opioid doses compared to the placebo-group; beta coefficient −0.56 (p = 0.03), i.e., 0.56 µg less fentanyl/h per week with vitamin D treatment. Vitamin D-reduced fatigue assessed with ESAS was −1.1 points after 12 weeks (p < 0.01). Antibiotic use or QoL did not differ significantly between the groups. The treatment was safe and well-tolerated. In conclusion, correction of vitamin D deficiency may have positive effects on opioid use and fatigue in palliative cancer patients, but only in those with a survival time more than 12 weeks.
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
-
Cancers
(Search for host publication in LIBRIS)
To the university's database